- Correction
- Open access
- Published:
Correction: Patient‑reported outcome (PRO) instruments used in patients undergoing adoptive cell therapy (ACT) for the treatment of cancer: a systematic review
Systematic Reviews volume 13, Article number: 117 (2024)
Correction: Syst Rev 12, 183 (2023)
Following publication of the original article [1], there was an error in the author name ‘Fiona Thistlewaite’ which should have been ‘Fiona Thistlethwaite’. The original article has been corrected.
Reference
Taylor S, Law K, Coomber-Moore J, et al. Patient-reported outcome (PRO) instruments used in patients undergoing adoptive cell therapy (ACT) for the treatment of cancer: a systematic review. Syst Rev. 2023;12:183. https://doi.org/10.1186/s13643-023-02337-8.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Taylor, S., Law, K., Coomber‑Moore, J. et al. Correction: Patient‑reported outcome (PRO) instruments used in patients undergoing adoptive cell therapy (ACT) for the treatment of cancer: a systematic review. Syst Rev 13, 117 (2024). https://doi.org/10.1186/s13643-024-02540-1
Published:
DOI: https://doi.org/10.1186/s13643-024-02540-1